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To the Editor: In the CHOICE dialysis cohort, Melamed
et al.1 found in their lagged analysis that intact PTH levels
o76 pg/ml were associated with a 35% lower mortality
compared to levels of 160–308 pg/ml. In order to appro-
priately discuss this observation in relation with National
Kidney Foundation-Kidney Disease Outcomes Quality In-
itiative optimal intact parathyroid hormone (PTH) of
150–300 pg/ml, we think that these figures have to be first
corrected by the 50% lower median bias induced by the
Diasorin intact PTH assay when compared with the Nicholls
Allegro assay to which Kidney Disease Outcomes Quality
Initiative is referring.2 This means that Allegro PTH
o150 pg/ml would be associated with a better survival than
PTH of 300–620 pg/ml. This certainly challenges the National
Kidney Foundation-Kidney Disease Outcomes Quality In-
itiative recommendation3 of preventing a PTH o150 pg/ml.
This is not too surprising as this recommendation was just
based on claims of a few authors (cited by Melamed) who
pointed out a link between low bone turnover and mortality.
Furthermore, this recommendation disregarded the results of
the bone histomorphometric study meta-analysis suggesting
that Allegro PTH o60 pg/ml best predicted low bone
turnover. It should be, however, noted that the observation
by Melamed et al. is in agreement with the most recent
prognostic evaluation of PTH by Block et al.,4 which, owing
to better adjustment with other comorbidities (specially
malnutrition), did not find anymore a higher mortality with
Allegro PTHo150 pg/ml, but found a higher mortality when
PTH was 4600 pg/ml.
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